Cargando…
Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management
Thrombocytopenia, defined as a platelet count <150,000/μL, is the most common complication of advanced liver disease or cirrhosis with an incidence of up to 75%. A decrease in platelet count can be the first presenting sign and tends to be proportionally related to the severity of hepatic failure...
Autor principal: | Scharf, Rüdiger E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038677/ https://www.ncbi.nlm.nih.gov/pubmed/33917431 http://dx.doi.org/10.3390/jcm10071530 |
Ejemplares similares
-
The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell, Oscar, et al.
Publicado: (2016) -
Pathophysiological Changes in the Hemostatic System and Antithrombotic Management in Kidney Transplant Recipients
por: van den Berg, Tamar A.J., et al.
Publicado: (2023) -
Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag
por: Tarantino, Michael D., et al.
Publicado: (2014) -
Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management
por: Khanam, Arshi, et al.
Publicado: (2021) -
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management
por: Patriarcheas, Vasileios, et al.
Publicado: (2020)